Expanded Hemodialysis Therapy Market Analysis

Type (Short Daily, Conventional Long-Term, Nocturnal)

The global expanded hemodialysis therapy market is segmented and analyzed for demand and supply by type into short daily, conventional long-term, and nocturnal. Out of the three types of hemodialysis, the conventional segment is estimated to gain the largest market share of about ~42% in the year 2035. The major factor attributed to the growth of the segment is the rising cases of kidney disorders that require dialysis on a regular basis. Also, the rising number of deaths owing to untreated kidney disease is estimated to fuel segment growth. Recent statistics published in 2023 revealed that approximately 1 million people die across the globe owing to untreated kidney failure each year. Also, the various advantages of conventional hemodialysis therapy such as high effectiveness, better results, positive outcomes, and enhanced patient experience are also expected to aid the expand the segment size during the forecast period.

End-user (Hospital, Independent Dialysis, Home Dialysis)

The global expanded hemodialysis therapy market is also segmented and analyzed for demand and supply by end-user into hospital, independent dialysis, and home dialysis. Amongst these three segments, the hospital segment is expected to garner a significant share of around ~46% in the year 2035 with a notable CAGR value. The major factors attributed to the growing segment size are the rising number of hospitals across the world and the presence of hospitals in every region coupled with rising investments by the government and key players for enhancing the hospital infrastructure. For instance, there were over 8,000 hospitals in Japan as of 2020. Korea, by contrast, had about 4,000 hospitals. In addition, there were more than 6000 hospitals in the United States. Furthermore, the rising preference of the global population to get treated in effective hospital settings and the availability of advanced medical devices and trained medical professionals to perform dialysis, and expanded hemodialysis therapy are also estimated to drive segment growth during the forecast period.

Our in-depth analysis of the global market includes the following segments:

By Product	Machines Dialyzers Concentrates Dialysates Catheters
By Type	Short Daily Conventional Long-Term Nocturnal
By Application	Priced Equipment Service Consumable, Drug
By End-user	Hospital Independent Dialysis Home Dialysis

Frequently Asked Questions (FAQ)

The major growth drivers for the market are the growing prevalence of diabetes and hypertension and increasing technological advancements to develop innovative therapies.

The market is anticipated to attain a CAGR of 5% over the forecast period, i.e., 2023-2035.

Complications and risks associated with dialysis coupled with the high cost associated with treatment are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are B. Braun Melsungen AG, Asahi Kasei Corporation, Baxter International, Inc., Fresenius Medical Care AG & Co. KGaA, Nikkiso Co., Ltd., Nipro Corporation, NxStage Medical, Inc., Cantel Medical Corp., Satellite Healthcare, Inc., MEDIVATORS, Inc., and other key players.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product, modality, end user, and by region.

The hospital segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

Expanded Hemodialysis Therapy Market Analysis